Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

T cell-mediated control of dermal fibroblast gene programs and dysfunction in scleroderma

Award Number: R21AI185642
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/12/2024
PERIOD OF PERFORMANCE END DATE: 04/30/2027

Group Awards By:

View Award Description

T cell-mediated control of dermal fibroblast gene programs and dysfunction in scleroderma - PROJECT SUMMARY/ABSTRACT Systemic sclerosis (SSc), also known as scleroderma, is an idiopathic disease of the connective tissue characterized by fibrosis of the skin and underlying organs. It has the highest mortality of all rheumatic conditions and no cure. T cells predominate in lesional SSc skin and patient serum is enriched in T cell cytokines. Immunosuppression that limits T cell function can decrease symptoms of fibrosis, but also increases patient susceptibility to infection. An array of functionally distinct T cells are in close-contact with fibroblasts in healthy skin, and dysregulated T cell-fibroblast crosstalk is thought to be a major driver of disease pathology. However, while T cells are implicated in SSc progression, no studies have performed a rigorous mechanistic dissection of T cell-directed changes to fibroblast gene programs in healthy and fibrotic skin. We previously identified a novel population of cutaneous CD4+CLA+CD103+ T cells in the blood and skin that co-produce IL-22 and IL-13 implicating a role in skin homeostasis. We now find that the frequency of these and other cutaneous T cells are altered in SSc, though their function in affected patient skin remains unexplored. Our novel preliminary data show that different cutaneous T cell populations promote distinct fibroblast gene signatures and demonstrate a strong CD103+ T cell-dependent effect on a newly identified SSc-associated fibroblast subset. We therefore hypothesize that CD103+ T cell activity is essential for fibroblast homeostasis at the steady state and that normal T cell-fibroblast interactions are disrupted in SSc, leading to fibroblast dysfunction. This proposal will use single- cell spatial transcriptomics and innovative organotypic skin culture to fill critical knowledge gaps and overcome existing technical hurdles in the field. Completion of these aims will build a foundation for the generation of exciting new hypothesis and will advance a novel organotypic culture model with the potential to recapitulate in vivo fibroblast heterogeneity associated with disease and tissue dysfunction.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON	1201 9TH AVE	SEATTLE	WA	98101	KING	USA	Allergy and Infectious Diseases Research	000	2	3/17/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $216,625 )
2025	2025	BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON	1201 9TH AVE	SEATTLE	WA	98101	KING	USA	Allergy and Infectious Diseases Research	000	2	4/25/2025	NON-COMPETING CONTINUATION	$216,625
														Subtotal = $216,625

Issue Date FY: 2024 ( Subtotal = $259,950 )
2024	2024	BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON	1201 9TH AVE	SEATTLE	WA	98101	KING	USA	Allergy and Infectious Diseases Research	001	1	9/11/2024	NEW	$25,995
2024	2024	BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON	1201 9TH AVE	SEATTLE	WA	98101	KING	USA	Allergy and Infectious Diseases Research	000	1	6/12/2024	NEW	$233,955
														Subtotal = $259,950

Grand Total All Awards = $476,575

Top

All Categories

About

Search

Reports

Data Submission

Award Information

T cell-mediated control of dermal fibroblast gene programs and dysfunction in scleroderma

Award Number: R21AI185642

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/12/2024

PERIOD OF PERFORMANCE END DATE: 04/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer